Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.

We investigated the role of prostaglandins in the hypercalcemia associated with neoplasia. In patients with hypercalcemia and solid tumors the excretion of the major urinary metabolite of the E prostaglandins, 7 alpha-hydroxy-5, 11-diketotetranorprostane-1, 16-dioic acid (PGE-M), was significantly greater than normal, P LESS THAN 0.01 (median of 58.4 and 7.1 ng per milligram of creatinine respectively). Slightly elevated values were seen in normocalcemic patients with solid tumors (14.3 ng per milligram). The levels of the metabolite were normal in hypercalcemic patients with either hematologic neoplasia or primary hyperparathyroidism. Immunoreactive parathyroid hormone was undetectable in the plasma of all hypercalcemic patients with solid tumors. Inhibition of prostaglandin synthesis by aspirin or indomethacin reduced excretion of both the urinary metabolite and serum calcium in six hypercalcemic patients with solid tumors and elevated excretion of the metabolite. These findings support the concept that prostaglandins are mediators of the hypercalcemia caused by certain solid tumors.

[1]  J. Shimazaki,et al.  Letter: Indomethacin-responsive hypercalcemia. , 1975, The New England journal of medicine.

[2]  R. Franklin,et al.  Hypercalcemia and tumor-prostaglandins: the VX2 carcinoma model in the rabbit. , 1975, Metabolism: clinical and experimental.

[3]  R. Franklin,et al.  Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat. , 1975, Endocrinology.

[4]  R. P. Robertson,et al.  Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma. , 1975, The Journal of clinical endocrinology and metabolism.

[5]  M. Hamberg,et al.  Prostaglandin endoperoxides IV. Effects on smooth muscle. , 1975, Life sciences.

[6]  G. Mundy,et al.  Evidence for the secretion of an osteoclast stimulating factor in myeloma. , 1974, The New England journal of medicine.

[7]  Lawrence G. Raisz,et al.  Complement-Dependent Stimulation of Prostaglandin Synthesis and Bone Resorption , 1974, Science.

[8]  B. Riggs,et al.  Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. , 1974, The Journal of clinical investigation.

[9]  V. Devita,et al.  Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. , 1974, The New England journal of medicine.

[10]  G. Mundy,et al.  Bone-resorbing activity in supernatants from lymphoid cell lines. , 1974, The New England journal of medicine.

[11]  M. Hamberg,et al.  Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. L. Willis.  An Enzymatic Mechanism for the Antithrombotic and Antihemostatic Actions of Aspirin , 1974, Science.

[13]  J. Oates,et al.  Display-oriented data system for multiple ion detection with gas chromatography-mass spectrometry in quantifying biomedically important compounds. , 1973, Analytical chemistry.

[14]  J. Potts,et al.  Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. , 1973, The New England journal of medicine.

[15]  F. Singer,et al.  Prostaglandins: effect on plasma calcium concentration. , 1973, Prostaglandins.

[16]  J. Habener,et al.  Parathyroid Hormone in Human Plasma: IMMUNOCHEMICAL CHARACTERIZATION AND BIOLOGICAL IMPLICATIONS. , 1972, The Journal of clinical investigation.

[17]  A. Tashjian,et al.  EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2 , 1972, The Journal of experimental medicine.

[18]  M. Hamberg,et al.  Inhibition of prostaglandin synthesis in man. , 1972, Biochemical and biophysical research communications.

[19]  J. Potts,et al.  Isolation of human parathyroid hormone. , 1974, Endocrinology.

[20]  M. Hamberg,et al.  On the Metabolism of Prostaglandins E1 and E2 in Man , 1971 .

[21]  B. Riggs,et al.  Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. , 1971, The Journal of clinical investigation.

[22]  D. Fink,et al.  Some thoughts on the nature of ectopic parathyroid hormones. , 1971, The American journal of medicine.

[23]  D. Klein,et al.  Prostaglandins: stimulation of bone resorption in tissue culture. , 1970, Endocrinology.

[24]  R. Knill-Jones,et al.  Hypercalcemia and increased parathyroid-hormone activity in a primary hepatoma. Studies before and after hepatic transplantation. , 1970, The New England journal of medicine.

[25]  G. Omenn,et al.  Hyperparathyroidism associated with malignant tumors of nonparathyroid origin , 1969, Cancer.

[26]  G. G. Rudolph,et al.  Determination of serum and urine calcium. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[27]  J. Potts,et al.  Production of parathyroid hormone by nonparthyroid tumors. , 1967, Journal of Clinical Endocrinology and Metabolism.

[28]  R. Yalow,et al.  Parathyroid Hormone in Plasma in Adenomatous Hyperparathyroidism, Uremia, and Bronchogenic Carcinoma , 1966, Science.

[29]  A. Tashjian,et al.  IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA , 1964, The Journal of experimental medicine.